D.J. St. Germain’s iShares US Pharmaceuticals ETF IHE Stock Holding History

D.J. St. Germain’s Portfolio IHE Stock Details IHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$14.3K	Buy	+144	New	+$13K	﹤0.01%	643
2023 Q3	–	Sell	-300	Closed	-$17.9K	–	769
2023 Q2	$17.9K	Buy	+300	New	+$17.8K	﹤0.01%	484

Other funds holding IHE

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

IWS

Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

D.J. St. Germain's IHE Position: Q2 2026 in Review

D.J. St. Germain opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 144 shares worth $14.3K. The stake represents ﹤0.01% of the portfolio and ranks #643 among its holdings. This is a return to the name: D.J. St. Germain previously reported a position in IHE as recently as Q2 2023.

D.J. St. Germain first reported a position in IHE in Q2 2023 and has held it in 2 quarters since. The position peaked at $17.9K in Q2 2023. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

D.J. St. Germain held 144 shares of iShares US Pharmaceuticals ETF worth $14.3K as of Q2 2026.
iShares US Pharmaceuticals ETF was a new D.J. St. Germain position in Q2 2026.
iShares US Pharmaceuticals ETF made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #643 holding.
D.J. St. Germain first reported a position in iShares US Pharmaceuticals ETF in Q2 2023 and has held it in 2 quarters since.
D.J. St. Germain's iShares US Pharmaceuticals ETF position peaked at $17.9K in Q2 2023.
210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.